ARQT
Arcutis Biotherapeutics, Inc. Common Stock ยท Health Care ยท NASDAQ
$26.66
โฒ $0.45 (+1.72%)
Market cap
$3.3B
52-week range
$13.06 โ $31.77
Volume
1.5M
Previous close
$26.21
Arcutis Biotherapeutics, Inc. Common Stock (ARQT) is held by 3 tracked hedge fund(s). Sector: Health Care. Largest tracked holder: Rubric Capital Management LP.
| Fund | % of portfolio | Shares | Value | Latest activity | Avg buy price | Date |
|---|---|---|---|---|---|---|
| Rubric Capital Management LP Rubric Capital Management LP |
2.1% | 8.3M | $195M | โ | $11.00 | 2026-03-31 |
| Polar Capital Holdings Plc Polar Capital Holdings Plc |
0.5% | 5.7M | $134M | โฒ 2.0% (+111K) | $11.00 | 2026-03-31 |
| GILDER GAGNON HOWE & CO LLC GILDER GAGNON HOWE & CO LLC |
1.2% | 4.3M | $101M | โผ 3.4% (โ150K) | $9.91 | 2026-03-31 |
Related โพ
FAQ โพ
Which hedge funds hold ARQT?
Tracked holders include: Rubric Capital Management LP, Polar Capital Holdings Plc, GILDER GAGNON HOWE & CO LLC.
How much smart money owns ARQT?
3 tracked hedge fund(s) have disclosed positions.
Are members of Congress trading ARQT?
No tracked Congressional trades in ARQT on file.
Where does this data come from?
SEC 13F filings (funds), Form 4 (insiders) and STOCK Act reports (Congress).
Sourced from SEC 13F, Form 4 & STOCK Act filings ยท Not investment advice โพ
Ownership from SEC filings; price from market data.
Published by WealthFile ยท Not investment advice.